北米の神経調節市場

◆英語タイトル:North America Internal Neuromodulation Market by Type (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Gastric Neuro stimulator), Application (Parkinson's Disease, Chronic pain) – Analysis & Forecast to 2019
◆発行会社/調査会社:MicroMarketMonitor 
◆商品コード:MMMNE-1002
◆発行日:2015年5月13日
◆調査対象地域:北米
◆産業分野:医療機器
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,650 ⇒換算¥296,800見積依頼/購入/質問フォーム
Multi User (Five User)USD3,250 ⇒換算¥364,000見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD4,505 ⇒換算¥504,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
MicroMarketMonitor 社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[北米の神経調節市場]についてメールでお問い合わせはこちら
当調査レポートでは、北米の神経調節市場について調査・分析し、エグゼクティブサマリー、市場概観、成長要因・阻害要因、種類別分析、用途別分析、主要国別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。
*** レポート概要(サマリー)***

The North American neuromodulation market is expected to reach $4,854.4 million by 2019 at a CAGR of 10.5% from 2014 to 2019.

Neuromodulation is defined as the use of technology to regulate the nervous system involving various processes, such as therapeutic alteration, stimulation, modification, inhibition, and others for the proper functioning of the body. This is carried out with the help of implantable devices. These devices are usually neural stimulators, which are used to treat various chronic and acute pain syndromes, dystonia, movement disorders, and spasticity. There are various types of stimulators that are usually used to stimulate the spinal cord and brain. The types include spinal cord stimulator, deep brain stimulator, gastric electrical stimulator, vagus nerve stimulator, and sacral nerve stimulator.

The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a higher market share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a higher market share of 85.9%in the neuromodulation market. Further, the market is segmented in terms of geography. Countries, such as the U.S., Canada, and Mexico are included in this market report. The market in the U.S. accounted for the highest share.

The report has profiled the leading players of this market along with the strategies (New product launches, approvals, and acquisitions) adopted by them to sustain and strengthen their position in the North America neuromodulation market. Medtronic Plc. (U.S.), St. Jude Medical (U.S.), Boston Scientific Corp. (U.S.), Cyberonics Inc. (U.S.), Biocontrol Medical (U.S.), and Greatbatch (U.S.) are some of the key players operating in this market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis ,market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the North America neuromodulation market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:
• Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the North America neuromodulation market. Usage pattern/penetration rate (in-depth trend analysis) of products (segment-wise) and purchasing data.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for North America neuromodulation market across geographies, exploit new distribution channels, new clientele base and different pricing policies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the North America neuromodulation market. Detailed description regarding the related and unrelated diversification pertaining to this market.
• Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies in the North America neuromodulation market.
• Product/Brand Perception Analysis: Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs.

*** レポート目次(コンテンツ)***

Table Of Contents

1 Introduction 9
1.1 Objectives Of The Study 9
1.2 Market Segmentation & Coverage 9
1.3 Stakeholders 10

2 Research Methodology 11
2.1 Integrated Ecosystem Of The Internal Neuromodulation Market 11
2.2 Arriving At The Internal Neuromodulation Market Size 12
2.2.1 Top-Down Approach 12
2.2.2 Bottom-Up Approach 14
2.2.3 Macroindicator-Based Approach 15
2.3 Assumptions 16

3 Executive Summary 17

4 Market Overview 19
4.1 Introduction 19
4.2 Internal Neuromodulation Market: Comparison With Neuromodulation (Parent) Market 19
4.3 Market Drivers And Inhibitors 21

5 North America Internal Neuromodulation Market, By Type 23
5.1 Introduction 24
5.2 North America Spinal Cord Stimulation Market, By Country 25
5.3 North America Deep Brain Stimulation Market, By Country 26
5.4 North America Sacral Nerve Stimulation Market, By Country 27
5.5 North America Vagus Nerve Stimulation Market, By Country 28
5.6 North America Gastric Electrical Stimulation Market, By Country 29

6 North America Internal Neuromodulation Market, By Application 30
6.1 Introduction 31
6.2 North America Internal Neuromodulation Market For Parkinson’S Disease, By Country 32
6.3 North America Internal Neuromodulation Market For Tremor,
By Country 33
6.4 North America Internal Neuromodulation Market For Depression,
By Country 34
6.5 North America Internal Neuromodulation Market For Other Applications, By Country 35

7 North America Internal Neuromodulation Market, By Geography 37
7.1 Introduction 38
7.2 U.S. Internal Neuromodulation Market 39
7.2.1 U.S. Internal Neuromodulation Market, By Application 40
7.2.2 U.S. Internal Neuromodulation Market, By Type 42
7.3 Canada Internal Neuromodulation Market 43
7.3.1 Canada Internal Neuromodulation Market, By Application 44
7.3.2 Canada: Internal Neuromodulation Market, By Type 46
7.4 Mexico Internal Neuromodulation Market 47
7.4.1 Mexico Internal Neuromodulation Market, By Application 48
7.4.2 Mexico Internal Neuromodulation Market, By Type 50

8 Competitive Landscape 52
8.1 Internal Neuromodulation Market, By Company 52
8.2 Company Presence In Internal Neuromodulation Market, By Type 53
8.3 New Product Launches 54
8.4 Regulatory Approvals 54

9 Company Profiles 55
(Overview, Financials, Products & Services, Strategy, And Developments)*
9.1 Boston Scientific Corporation 55
9.2 Cerbomed Gmbh 58
9.3 Cyberonics, Inc. 59
9.4 Depuy Synthes Companies 61
9.5 Enteromedics, Inc. (U.S.) 64
9.6 Medtronic, Inc. (U.S.) 66
9.7 St. Jude Medical 69
9.8 Synapse Biomedical, Inc. 72
9.9 Uroplasty, Inc. (U.S.) 73
*Details On Overview, Financials, Product & Services, Strategy, And Developments Might Not Be Captured In Case Of Unlisted Company

10 Appendix 75
10.1 Customization Options 75
10.1.1 Product Analysis 75
10.1.2 Epidemiology Data 75
10.1.3 Surgeons/Physicians Perception Analysis 75
10.1.4 Regulatory Framework 75

10.2 Related Reports 76
10.3 Introducing Rt: Real-Time Market Intelligence 77
10.3.1 Snapshots 78

List Of Tables

Table 1 Global Internal Neuromodulation Peer Market Size, 2014 (Usd Mn) 13
Table 2 North American Internal Neuromodulation Market: Macroindicators,
By Country, 2013 (Usd Mn) 15
Table 3 North America: Internal Neuromodulation Market: Comparison With Neuromodulation (Parent) Market, 2013 – 2019 (Usd Mn) 20
Table 4 North America: Internal Neuromodulation Market, By Type,
2013 - 2019 (Usd Mn) 20
Table 5 North America Internal Neuromodulation Market: Drivers And Inhibitors 21
Table 6 North America: Internal Neuromodulation Market, By Type,
2013 - 2019 (Usd Mn) 24
Table 7 North America: Spinal Cord Stimulation Market, By Country,
2013–2019 (Usd Mn) 25
Table 8 North America: Deep Brain Stimulation Market, By Country,
2013–2019 (Usd Mn) 26
Table 9 North America: Sacral Nerve Stimulation Market, By Country,
2013 - 2019 (Usd Mn) 27
Table 10 North America: Vagus Nerve Stimulation Market, By Country,
2013 - 2019 (Usd Mn) 28
Table 11 North America: Gastric Electrical Market, By Country,
2013 - 2019 (Usd Mn) 29
Table 12 North America: Internal Neuromodulation Market, By Application,
2013 - 2019 (Usd Mn) 32
Table 13 North America: Internal Neuromodulation Market For Parkinson’S Disease, By Country, 2013 - 2019 (Usd Mn) 33
Table 14 North America: Internal Neuromodulation Market For Tremor,
By Country, 2013 - 2019 (Usd Mn) 34
Table 15 North America: Internal Neuromodulation Market For Depression,
By Country, 2013 - 2019 (Usd Mn) 35
Table 16 North America: Internal Neuromodulation Market For Other Applications, By Country, 2013 - 2019 (Usd Mn) 36
Table 17 North America: Internal Neuromodulation Market, By Country,
2013 - 2019 (Usd Mn) 38
Table 18 U.S.: Internal Neuromodulation Market, By Application,
2013-2019 (Usd Mn) 40
Table 19 U.S.: Internal Neuromodulation Market, By Type, 2013 - 2019 (Usd Mn) 42
Table 20 Canada: Internal Neuromodulation Market, By Application,
2013-2019 (Usd Mn) 44
Table 21 Canada: Internal Neuromodulation Market, By Type, 2013 - 2019 (Usd Mn) 46
Table 22 Mexico: Internal Neuromodulation Market, By Application,
2013-2019 (Usd Mn) 48
Table 23 Mexico: Internal Neuromodulation Market, By Type, 2013 - 2019 (Usd Mn) 50
Table 24 Internal Neuromodulation Market: By Company 52
Table 25 Internal Neuromodulation Market: Company Share Analysis, 2013(%) 52
Table 26 North America Internal Neuromodulation Market: New Product Launches 54
Table 27 North America Internal Neuromodulation Market: Regulatory Approvals 54
Table 28 Boston Scientific Corporation: Key Financials, By Segment,
2009 - 2013 (Usd Mn) 56
Table 29 Boston Scientific Corporation: Key Financials, By Region,
2009 - 2012 (Usd Mn) 56
Table 30 Cyberonics, Inc.: Key Financials, 2009 - 2013 (Usd Mn) 59
Table 31 Johnson & Johnson, Inc. : Key Financials, By Segment, 2009 - 2013 (Usd Mn) 62
Table 32 Johnson & Johnson, Inc.: Key Financials, 2009 - 2013 (Usd Mn) 62
Table 33 Medtronic, Inc.: Key Financials, By Segment, 2009 - 2013 (Usd Mn) 67
Table 34 Medtronic, Inc.: Key Financials, 2009 - 2013 (Usd Mn) 67
Table 35 St. Jude Medical: Key Financials, By Segment, 2011 - 2013 (Usd Mn) 69
Table 36 St. Jude Medical: Key Financials, By Geography, 2009 - 2013 (Usd Mn) 70
Table 37 Uroplasty, Inc.: Key Financials, By Country, 2010 - 2013 (Usd Mn) 73



List Of Figures

Figure 1 North American Internal Neuromodulation Market: Segmentation & Coverage 10
Figure 2 Internal Neuromodulation Market: Integrated Ecosystem 11
Figure 3 Research Methodology 12
Figure 4 Top-Down Approach 13
Figure 5 Bottom-Up Approach 14
Figure 6 Macroindicator-Based Approach 15
Figure 7 North American Internal Neuromodulation Market Snapshot 18
Figure 8 Internal Neuromodulation Market: Comparison With Neuromodulation (Parent) Market 19
Figure 9 North America Internal Neuromodulation Market, By Type, 2013 (Usd Mn) 20
Figure 10 North America Internal Neuromodulation Market, By Type,
2014 Vs. 2019 (Usd Mn) 24
Figure 11 North America Spinal Cord Stimulation Market, By Country,
2013–2019 (Usd Mn) 25
Figure 12 North America Deep Brain Stimulation Market, By Country,
2013–2019 (Usd Mn) 26
Figure 13 North America: Sacral Nerve Stimulation Market, By Country,
2013 - 2019 (Usd Mn) 27
Figure 14 North America Vagus Nerve Stimulation Market, By Country,
2013 – 2019 (Usd Mn) 28
Figure 15 North America Gastric Electrical Market, By Country, 2013 - 2019 (Usd Mn) 29
Figure 16 North America: Internal Neuromodulation Market, By Application,
2013 - 2019 (Usd Mn) 31
Figure 17 North America: Internal Neuromodulation Market For Parkinson’S Disease, By Country, 2013 - 2019 (Usd Mn) 32
Figure 18 North America: Internal Neuromodulation Market For Tremor,
By Country, 2013 - 2019 (Usd Mn) 33
Figure 19 North America: Internal Neuromodulation Market For Depression,
By Country, 2013 - 2019 (Usd Mn) 34
Figure 20 North America: Internal Neuromodulation Market For Other Applications, By Country, 2013 - 2019 (Usd Mn) 35
Figure 21 North America: Internal Neuromodulation Market: Growth Analysis,
By Geography, 2013-2019 (Usd Mn) 38
Figure 22 U.S. Internal Neuromodulation Market Overview, 2014 & 2019 (%) 39
Figure 23 U.S. Internal Neuromodulation Market, By Application, 2013-2019 (Usd Mn) 40
Figure 24 U.S. Internal Neuromodulation Market: Application Snapshot,
2014 Vs. 2019 41
Figure 25 U.S. Internal Neuromodulation Market, By Type, 2013 - 2019 (Usd Mn) 42
Figure 26 U.S. Internal Neuromodulation Market Share, By Type, 2014 Vs. 2019 (%) 43
Figure 27 Canada Internal Neuromodulation Market Overview, 2014 & 2019 (%) 43
Figure 28 Canada Internal Neuromodulation Market, By Application,
2013-2019 (Usd Mn) 44
Figure 29 Canada Internal Neuromodulation Market: Application Snapshot,
2014 Vs. 2019 45
Figure 30 Canada Internal Neuromodulation Market, By Type, 2013 - 2019 (Usd Mn) 46
Figure 31 Canada Internal Neuromodulation Market Share, By Type, 2014 Vs.2019 (%) 47
Figure 32 Mexico Internal Neuromodulation Market Overview, 2014 & 2019 (%) 47
Figure 33 Mexico Internal Neuromodulation Market, By Application,
2013 - 2019 (Usd Mn) 48
Figure 34 Mexico Internal Neuromodulation Market: Application Snapshot,
2014 Vs. 2019 49
Figure 35 Mexico Internal Neuromodulation Market, By Type, 2013- 2019 (Usd Mn) 50
Figure 36 Mexico Internal Neuromodulation Market Share, By Type, 2014 Vs. 2019 (%) 51
Figure 37 Internal Neuromodulation: Company Product Coverage, By Type, 2013 53
Figure 38 Boston Scientific Corporation: Business Revenue Mix, 2013 55
Figure 39 Johnson & Johnson, Inc.: Revenue Mix, 2013 61
Figure 40 Medtronic, Inc.: Revenue Mix, 2013 66
Figure 41 St. Jude Medical: Revenue Mix, 2013 69



*** レポートのキーワード ***

神経調節、脊髄刺激、深部脳刺激

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MMMNE-1002 )"北米の神経調節市場" (英文:North America Internal Neuromodulation Market by Type (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Gastric Neuro stimulator), Application (Parkinson's Disease, Chronic pain) – Analysis & Forecast to 2019)はMicroMarketMonitor 社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。